FeNO Testing Made Simple
Overview
NIOX VERO® is a clinically validated device that measures Fractional Exhaled Nitric Oxide (FeNO) – a key biomarker for airway inflammation in asthma diagnosis and management. It provides quick, reliable, and non-invasive results to help healthcare professionals assess airway inflammation and optimise treatment.
Why FeNO Testing?
FeNO testing with NIOX VERO® helps:
- Confirm asthma diagnosis by identifying airway inflammation.
- Optimise inhaled corticosteroid treatment for better patient outcomes.
- Monitor asthma control and adjust medication as needed.
- Differentiate between asthma and other respiratory conditions like COPD.
Key Features
- Fast & Easy to Use – Results in just 1 minute with a simple exhalation.
- Non-Invasive & Comfortable – Suitable for adults and children aged 4+.
- Accurate & Reliable – Used in leading asthma guidelines (GINA, ERS, ATS).
- Portable & Battery-Powered – Ideal for clinics, hospitals, and mobile healthcare units.
- No Calibration Needed – Ready to use with minimal maintenance.
Who Can Benefit?
- General Practitioners & Pulmonologists – Improve asthma diagnosis and management.
- Occupational Health Clinics – Assess workplace respiratory risks.
- Allergy & Respiratory Specialists – Differentiate between asthma and allergies.
- Mobile & Rural Healthcare Services – Provide quick asthma screening anywhere.
Why Choose NIOX VERO®?
- Gold Standard in FeNO Testing – Backed by global clinical research.
- Improves Treatment Decisions – Helps avoid unnecessary medication.
- Enhances Patient Care – Ensures better asthma control and fewer exacerbations.